Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's Disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Rakshit, Hindol ^a   Rathi, Nitin ^b   Roy, Debjani ^c  

^a VISVA BHARATI UNIVERSITY   (India)

^b Maharashtra Industrial Development Corporation India   (India)

^c BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NEUROTRANSMITTER; PROTEIN; TRANSCRIPTOME;

ARTICLE; AUTOPSY; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FRONTAL CORTEX; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC SELECTION; HUMAN; HUMAN TISSUE; MARKER GENE; MICROARRAY ANALYSIS; PARKINSON DISEASE; PARKINSONISM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SUBSTANTIA NIGRA; BRAIN; GENETICS; METABOLISM; PATHOLOGY; PROTEOMICS;

BRAIN; GENE EXPRESSION PROFILING; HUMANS; PARKINSON DISEASE; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEINS; PROTEOMICS; SUBSTANTIA NIGRA; TRANSCRIPTOME;

EID: 84922800205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103047     Document Type: Article

References (69)

1. Pankratz ND, Wojcieszek J, Foroud T (2004) Parkinson Disease Overview. Seattle (WA): University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/ books/NBK1223/ Accessed 2013 17th Aug.
2. Samii A, Nutt JG, Ransom BR (2004) Parkinson's disease. Lancet 363 (9423): 1783-93. (Pubitemid 38698383)
3. Davie CA (2008) A review of Parkinson's disease. Br Med Bull 86 (1): 109-27.
4. Lesage S, Brice A (2009) Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18 (R1): R48-59.
5. Barabási AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5(2) 101-113.
6. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, et al. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 27(2):199-204.
7. Lee SA, Tsao TT, Yang KC, Lin H, Kuo YL, et al. (2011) Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics 12 (Suppl 13):S20.
8. Ran J, Li H, Fu J, Liu L, Xing Y, et al. (2013) Construction and analysis of the protein-protein interaction network related to essential hypertension. BMC Systems Biology 7:32.
9. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F (2004) A Model-Based Background Adjustment for Oligonucleotide Expression Arrays. Journal of the American Statistical Association vol 99 page 909-917. (Pubitemid 39665934)
10. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, et al. (2006) Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 7(1):1-11. (Pubitemid 43327678)
11. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121. (Pubitemid 32397092)
12. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA (2003) Identifying Biological Themes within Lists of Genes with EASE. Genome Biology 4(10):R70.
13. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38:W210-3.
14. Al-Shahrour F, Minguez P, Tarraga J, Medina I, Alloza E, et al. (2007) FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 35:W91-6.
15. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27-30. (Pubitemid 30047706)
16. Dannenfelser R, Clark NR, Ma'ayan A (2012) Genes2FANs: connecting genes through functional association networks. BMC Bioinformatics 13:156.
17. Lee SA, Chan CH, Chen TC, Yang CY, Huang KC, et al. (2009) POINeT: protein interactome with sub-network analysis and hub prioritization. BMC Bioinformatics 10:114.
18. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498-504. (Pubitemid 37428274)
19. Becker MY, Rojas I (2001) A graph layout algorithm for drawing metabolic pathways. Bioinformatics 17(5): 461-7. (Pubitemid 32440307)
20. Yip KY, Yu H, Kim PM, Schultz M, Gerstein M (2006) The tYNA platform for comparative interactomics: a web tool for managing, comparing and mining multiple networks. Bioinformatics 22(23):2968-70. (Pubitemid 44811577)
21. Ray M, Ruan J, Zhang W (2008) Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome Biol 9(10):R148.
22. Ruepp A, Waegele B, Lechner M, Brauner B, Dunger-Kaltenbach I, et al. (2010) CORUM: the comprehensive resource of mammalian protein complexes-2009. Nucleic Acids Res 38:D497-501.
23. Barone P (2010) Neurotransmission in Parkinson's disease: beyond dopamine. European Journal of Neurology 17 (3): 364-376.
24. Dumitriu A, Latourelle JC, Hadzi TC, Pankratz N, Garza D, et al. (2012) Gene Expression Profiles in Parkinson Disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet 8(6): e1002794.
25. Ferrer I, Martinez A, Blanco R, Dalfo E, Carmona M (2011) Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm 118(5): 821-839.
26. Gomez A, Ferrer I (2010) Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Acta Neuropathol 120(2):155-67.
27. Chu G, Narasimhan B, Tibshirani R, Tusher V. SAM "Significance Analysis of Microarrays" Users Guide and technical document.
28. Chatterjee P, Bhattacharyya M, Bandyopadhyay S, Roy D (2014) Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease. PLoS ONE 9(4): e93751.
29. Batada NN, Hurst LD and Tyers M (2006) Evolutionary and physiological importance of hub proteins. PLoS Comput Biol 2(7): e88.
30. Coulomb S, Bauer M, Bernard D, Marsolier-Kergoat MC (2005) Gene essentiality and the topology of protein interaction networks. Proc Biol Sci 272(1573): 1721-1725. (Pubitemid 41414681)
31. He X, Zhang J (2006) Why do hubs tend to be essential in protein networks? PLoS Genet 2(6):e88.
32. Friedel CC and Zimmer R (2007) Influence of degree correlations on network structure and stability in protein-protein interaction networks. BMC Bioinformatics 8: 297.
33. Goñi J, Esteban FJ, de Mendizábal NV, Sepulcre J, Ardanza-Trevijano S, et al. (2008) A computational analysis of protein-protein interaction networks in neurodegenerative diseases. BMC Systems Biology 2:52.
34. Joy MP, Brock A, Ingber DE, Huang S (2005) High-betweenness proteins in the yeast protein interaction network. J Biomed Biotechnol 2, 96-103. (Pubitemid 41627865)
35. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M (2007) The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol 3(4): e59.
36. Gursoy A, Keskin O, Nussinov R (2008) Topological properties of protein interaction networks from a structural perspective. Biochem Soc Trans 36(Pt 6): 1398-1403.
37. Chen TC, Lee SA, Chan CH, Juang YL, Hong YR, et al. (2009) Cliques in mitotic spindle network bring kinetochore-associated complexes to form dependence pathway. Proteomics 9 (16):4048-4062.
38. Spirin V, Mirny LA (2003) Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci USA 100 (21):12123-12128. (Pubitemid 37271525)
39. Wall DP, Pivovarov R, Tong M, Jung JY, Fusaro VA, et al. (2010) Genotator: A disease-agnostic tool for genetic annotation of disease. BMC Medical Genomics 3:50.
40. Kim SJ, Sung JY, Um JW, Hattori N, Mizuno Y, et al. (2003) Parkin cleaves intracellular alpha-Synuclein inclusions via the activation of calpain. J Biol Chem 278(43): 41890-41899. (Pubitemid 37310450)
41. Björk K, Tronci V, Thorsell A, Tanda G, Hirth N, et al. (2013) β-Arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol. Psychopharmacology (Berl) 230(3):439-49.
42. Thathiah A, Horré K, Snellinx A, Vandewyer E, Huang Y, et al. (2013) β-barrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease. Nat Med 19(1):43-9.
43. Mishima T, Fujiwara T, Kofuji T, Akagawa K (2012) Impairment of catecholamine systems during induction of long-term potentiation at hippocampal CA1 synapses in HPC-1/syntaxin 1A knock-out mice. J Neurosci 32(1):381-9.
44. Cervinski MA, Foster JD, Vaughan RA (2010) Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience 170(2):408-16.
45. Nakamura K, Anitha A, Yamada K, Tsujii M, Iwayama Y, et al. (2008) Genetic and expression analyses reveal elevated expression of syntaxin 1A (STX1A) in high functioning autism. Int J Neuropsychopharmacol 11(8):1073-84.
46. Nakamura K, Iwata Y, Anitha A, Miyachi T, Toyota T, et al. (2011) Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility. Prog Neuropsychopharmacol Biol Psychiatry 35(2):454-8.
47. Bragina L, Giovedí S, Barbaresi P, Benfenati F, Conti F (2010) Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex: analysis of synaptogyrin, vesicle-associated membrane protein, and syntaxin. Neuroscience 165(3):934-43.
48. Jellen LC, Lu L, Wang X, Unger EL, Earley CJ, et al. (2013) Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice. Neuroscience 252:13-23.
49. Lu D, Yang H, Lenox RH, Raizada MK (1998) Regulation of angiotensin II-induced neuromodulation by MARCKS in brain neurons. J Cell Biol 142(1):217-27. (Pubitemid 28341152)
50. Ouimet CC, Wang JK, Walaas SI, Albert KA, Greengard P (1990) Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain. J Neurosci 10(5):1683-98.
51. Satoh K, Matsuki-Fukushima M, Qi B, Guo MY, Narita T, et al. (2009) Phosphorylation of myristoylated alanine-rich C kinase substrate is involved in the cAMP-dependent amylase release in parotid acinar cells. Am J Physiol Gastrointest Liver Physiol 296(6):G1382-90.
52. Fitzgerald PJ, Barkus C, Feyder M, Wiedholz LM, Chen YC, et al. (2010) Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiol Dis 40(3):608-21.
53. Gao L, Gao H, Zhou H, Xu Y (2013) Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson's disease. BMC Neurol 13:181.
54. Xenarios I, Rice DW, Salwinski L, Baron MK, Marcotte EM, et al. (2000) DIP: the database of interacting proteins. Nucleic Acids Res 28(1):289-291. (Pubitemid 30047782)
55. Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M et al. (2002) MINT: a Molecular INTeraction database. FEBS Lett 513(1):135-140. (Pubitemid 34242991)
56. Bader GD, Betel D, Hogue CW (2003) BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 31 (1):248-250. (Pubitemid 36150376)
57. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37: D767-772.
58. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, et al. (2006) BioGRID: a general repository for interaction datasets. Nucleic Acids Res 34 Database:D535-539.
59. Lynn DJ, Winsor GL, Chan C, Richard N, Laird MR, et al. (2008) InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol 4:218.
60. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38:D355-D360.
61. Aranda B, Achuthan P, Alam-Faruque Y, Armean I, Bridge A, et al. (2010) The IntAct molecular interaction database in 2010. Nucleic Acids Res 38:D525-D531.
62. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, et al. (2004) The HUPO PSI's molecular interaction format-a community standard for the representation of protein interaction data. Nat Biotechnol 22(2):177-183. (Pubitemid 38160532)
63. Ma'ayan A, Jenkins SL, Neves S, Hasseldine A, Grace E, et al. (2005) Formation of regulatory patterns during signal propagation in a mammalian cellular network. Science 309(5737):1078-1083. (Pubitemid 41134466)
64. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122(6):957-968. (Pubitemid 41345212)
65. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437(7062):1173-1178. (Pubitemid 41509356)
66. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920.
67. Mewes HW, Amid C, Arnold R, Frishman D, Guldener U, et al. (2004) MIPS: analysis and annotation of proteins from whole genomes. Nucleic Acids Res 32: D41-44. (Pubitemid 38081600)
68. Guldener U, Munsterkotter M, Kastenmuller G, Strack N, van Helden J, et al. (2005) CYGD: the Comprehensive Yeast Genome Database. Nucleic Acids Res 33:D364-368. (Pubitemid 40207896)
69. Güldener U, Münsterkötter M, Oesterheld M, Pagel P, Ruepp A, et al. (2006) MPact: the MIPS protein interaction resource on yeast. Nucleic Acids Res 34:D436-D441.